United Therapeutics | UTHR - Capitalización De Mercado

Precio De Mercado
567.16
Cambio Diario
-5.69 -0.99%
Mensual
4.72%
Anual
94.65%
Q2 Expectativa
555.02




Capitalización De Mercado Cambio Fecha
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.42B 89M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 561.65B 17.5B 2026-04
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12